申请人:Janssen Pharmaceutica NV
公开号:US07893257B2
公开(公告)日:2011-02-22
The present invention is directed to a novel process for the preparation of piperazinyl and diazepanyl benzamide derivatives, useful for the treatment of disorders and conditions mediated by a histamine receptor, preferably the H3 receptor.
本发明涉及一种新的制备
哌嗪基和二氮平基苯甲酰胺衍
生物的方法,用于治疗由
组胺受体介导的疾病和症状,特别是H3受体。